|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/08 | |
| A61P 5/02 | |||
| A61K 9/00 |
| (11) | Patento numeris | 1830806 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05804975.0 |
| Europos patento paraiškos padavimo data | 2005-12-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-09-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-09-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2005/013703 |
| Data | 2005-12-20 |
| (87) | Numeris | WO 2006/066868 |
| Data | 2006-06-29 |
| (30) | Numeris | Data | Šalis |
| 0428151 | 2004-12-22 | GB |
| (72) |
LAMBERT, Olivier, FR
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | SUSTAINED RELEASE FORMULATION COMPRISING A SOMATOSTATIN ANALOGUE |
| SUSTAINED RELEASE FORMULATION COMPRISING A SOMATOSTATIN ANALOGUE |